136 related articles for article (PubMed ID: 18165633)
1. Treatment of advanced non small-cell lung cancer in the elderly: from best supportive care to the combination of platin-based chemotherapy and targeted therapies.
Gridelli C
J Clin Oncol; 2008 Jan; 26(1):13-5. PubMed ID: 18165633
[No Abstract] [Full Text] [Related]
2. Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"?
Gandara DR; Hesketh P
Clin Lung Cancer; 2005 Nov; 7(3):154-5. PubMed ID: 16354308
[No Abstract] [Full Text] [Related]
3. The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis.
Chen S; Zhang J; Wang R; Luo X; Chen H
Lung Cancer; 2010 Oct; 70(1):63-70. PubMed ID: 20541281
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for lung cancer.
Feliu J; Espinosa E; Sánchez JJ
N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088319
[No Abstract] [Full Text] [Related]
5. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
Socinski MA
J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
[No Abstract] [Full Text] [Related]
6. Chemotherapy for lung cancer: the state of the art in 2009.
Higgins MJ; Ettinger DS
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options for elderly patients with advanced non-small cell lung cancer.
Avery EJ; Kessinger A; Ganti AK
Cancer Treat Rev; 2009 Jun; 35(4):340-4. PubMed ID: 19155139
[TBL] [Abstract][Full Text] [Related]
8. Promising results achieved with a combination of chemotherapy and two retinoids in patients with advanced non-small-cell lung cancer.
Nandan R
Lung Cancer; 2006 Mar; 51(3):387-8. PubMed ID: 16406137
[No Abstract] [Full Text] [Related]
9. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
[TBL] [Abstract][Full Text] [Related]
11. [The changed role of chemotherapy in the treatment of stage III non-small-cell lung carcinoma].
Belderbos JS; Bartelink H; Boersma LJ; Aleman BM
Ned Tijdschr Geneeskd; 1997 Jul; 141(30):1498-9. PubMed ID: 9542887
[No Abstract] [Full Text] [Related]
12. Platin or no platin? That is the question.
Schiller JH
J Clin Oncol; 2003 Aug; 21(16):3009-10. PubMed ID: 12837812
[No Abstract] [Full Text] [Related]
13. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
Besse B; Le Chevalier T
J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
[No Abstract] [Full Text] [Related]
14. Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue.
Petrelli F; Ghilardi M; Cremonesi M; Cabiddu M; Barni S
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1455-65. PubMed ID: 19828007
[TBL] [Abstract][Full Text] [Related]
15. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA
J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938
[TBL] [Abstract][Full Text] [Related]
16. [Combination chemotherapy for treatment of metastasing non-small-cell lung carcinoma. Monotherapy of combinations of two or three agents--a survey of a Cochrane review].
Mellemgaard A; Pappot H
Ugeskr Laeger; 2009 Jun; 171(25):2084-7. PubMed ID: 19671386
[No Abstract] [Full Text] [Related]
17. Targeted therapies in non-small-cell lung cancer: a paradigm in evolution.
Sangha R; Lara PN; Mack P; Gandara DR
Clin Lung Cancer; 2008; 9 Suppl 3():S90-1. PubMed ID: 19419929
[No Abstract] [Full Text] [Related]
18. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():37-46. PubMed ID: 18263773
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for lung cancer.
Locke I; Gillham CM
N Engl J Med; 2002 May; 346(19):1498; author reply 1498. PubMed ID: 12000824
[No Abstract] [Full Text] [Related]
20. [Treatment of non-small cell lung cancer: advanced (metastatic) disease. Guidelines of clinical practice made by the European Lung Cancer Working Party].
European Lung Cancer Working Party
Rev Med Brux; 2007; 28(6):495-511. PubMed ID: 18265809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
